Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21591943 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
Condition: Kidney Transplantation
Interventions: Drug: basiliximab;   Drug: rabbit anti-thymocyte globulin;   Drug: tacrolimus;   Drug: alemtuzumab;   Drug: mycophenolate mofetil;   Drug: steroids

Indicates status has not been verified in more than two years